Trulieve Cannabis Corp. SEC filings TRLV
Trulieve Cannabis Corp. has 416 filings in SEC EDGAR's recent list, going back to Oct 2, 2018. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POSASR | Filing | Aug 24, 2026 | — |
| CERT | Nyse certification | Jun 9, 2026 | — |
| 8-A12B | Filing | Jun 9, 2026 | — |
| D | Filing | Feb 6, 2026 | — |
| D | Filing | Dec 29, 2025 | — |
| DEFR14A | Filing | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2023 | — |
| CORRESP | Letter to the SEC | Apr 5, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2023 | — |
| NT 10-K | Filing | Feb 24, 2023 | Dec 31, 2022 |
| CORRESP | Letter to the SEC | Jan 10, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2022 | — |
| EFFECT | Filing | Jul 11, 2022 | — |
| EFFECT | Filing | Jul 11, 2022 | — |
| EFFECT | Filing | Jan 28, 2022 | — |
| CORRESP | Letter to the SEC | Jan 26, 2022 | — |
| EFFECT | Filing | Jan 25, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2022 | — |
| D | Filing | Oct 13, 2021 | — |
| EFFECT | Filing | Sep 20, 2021 | — |
| D | Filing | Jun 23, 2021 | — |
| AW | Filing | Apr 8, 2021 | — |
| POS EX | Filing | Apr 8, 2021 | — |
| EFFECT | Filing | Apr 7, 2021 | — |
| CORRESP | Letter to the SEC | Apr 5, 2021 | — |
| CORRESP | Letter to the SEC | Apr 5, 2021 | — |
| EFFECT | Filing | Mar 29, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2021 | — |
| EFFECT | Filing | Feb 4, 2021 | — |
| CORRESP | Letter to the SEC | Feb 2, 2021 | — |
| 8-A12G | Form 8-a12g | Feb 2, 2021 | — |
| CORRESP | Letter to the SEC | Jan 12, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2020 | — |
| DRS/A | Filing | Dec 11, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2020 | — |
| DRS | Filing | Oct 22, 2020 | — |
| D | Filing | Oct 2, 2018 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- TRLV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Tallahassee, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1754195
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.